Harpagoside

Harpagoside (CAS 19210-12-9) is an iridoid glycoside isolated from the roots of Harpagophytum procumbens, commonly known as Devil’s Claw. It is the primary bioactive marker used for standardizing Devil’s Claw extracts, known for its anti-inflammatory and analgesic properties. We supply Harpagoside in a range of concentrations (3% to 20%) to meet different formulation needs, from dietary supplements to pharmaceutical research.

Synonyme: Harpagoside, (1S,4aS,5R,7S,7aR)-1-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-7a-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid methyl ester, Harpagophytum procumbens extract, Devil’s Claw extract

Anwendungen

• Joint health and mobility supplements
• Anti-inflammatory formulations
• Sports nutrition and recovery products
• R&D for pharmaceutical applications

Qualität und Dokumentation

Each batch is tested for assay (HPLC), loss on drying, and heavy metals. We provide COA, MSDS, and TDS per batch. Stability data is available upon request for your qualification process.

Verpackung und Beschaffung

Standardverpackungen: 1 kg, 5 kg, 25 kg; Großmengen und Sonderverpackungen sind ebenfalls erhältlich. Lagerware wird innerhalb von 3–5 Tagen versandt; Mindestbestellmenge ab 1 kg. Für Preisauskünfte und Muster wenden Sie sich bitte an unser Vertriebsteam.

Angebotsanfrage

• Unsere Adresse: 280 Main Street, Xi’an, Shaanxi, China
• LyvBio GmbH. — E-Mail: info@lyvbio.com